Showing results (1-10 of 14) with videos related to

Sort By:
Pageof 2
International Journal of Cancer|October 5, 2017
Role of interferon regulatory factor 1 in governing Treg depletion, Th1 polarization, inflammasome activation and antitumor efficacy of cyclophosphamideCarla Buccione, Alessandra Fragale, Federica Polverino, et al.
Frontiers in Immunology|November 29, 2018
The Pleiotropic Immunomodulatory Functions of IL-33 and Its Implications in Tumor ImmunityClaudia Afferni, Carla Buccione, Sara Andreone, et al.
Stem Cells International|March 25, 2017
Gut Mesenchymal Stromal Cells in ImmunityValeria Messina, Carla Buccione, Giulia Marotta, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 14, 2013
Cyclophosphamide induces a type I interferon-associated sterile inflammatory response signature in cancer patients' blood cells: implications for cancer chemoimmunotherapyFederica Moschella, Giovanni Fernando Torelli, Mara Valentini, et al.
Frontiers in Oncology|June 5, 2023
Blood immune cells as potential biomarkers predicting relapse-free survival of stage III/IV resected melanoma patients treated with peptide-based vaccination and interferon-alphaFederica Moschella, Carla Buccione, Irene Ruspantini, et al.
Cells|April 16, 2020
Tumor-Intrinsic or Drug-Induced Immunogenicity Dictates the Therapeutic Success of the PD1/PDL Axis BlockadeAlessandra Rossi, Valeria Lucarini, Iole Macchia, et al.
Oncoimmunology|July 7, 2017
IL-33 restricts tumor growth and inhibits pulmonary metastasis in melanoma-bearing mice through eosinophilsValeria Lucarini, Giovanna Ziccheddu, Iole Macchia, et al.
Journal of Experimental & Clinical Cancer Research : CR|May 2, 2025
Decitabine co-operates with the IL-33/ST2 axis modifying the tumor microenvironment and improving the response to PD-1 blockade in melanomaFrancesco Noto, Jacopo Mancini, Adriana Rosa Gambardella, et al.
Cancers|November 14, 2019
IL-33 Promotes CD11b/CD18-Mediated Adhesion of Eosinophils to Cancer Cells and Synapse-Polarized Degranulation Leading to Tumor Cell KillingSara Andreone, Francesca Spadaro, Carla Buccione, et al.
Journal of Translational Medicine|May 3, 2015
Intratumoral injection of IFN-alpha dendritic cells after dacarbazine activates anti-tumor immunity: results from a phase I trial in advanced melanomaCarmela Rozera, Giancarlo Antonini Cappellini, Giuseppina D'Agostino, et al.
Pageof 2